你即將離開本站

並前往https://pubmed.ncbi.nlm.nih.gov/34186022/

a double-blind, randomised, phase 3 trial - PubMed

... 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial ... This study is registered with ClinicalTrials.gov, NCT03954834.

確定！ 回上一頁

查詢 「SURPASS study」的人也找了：

  1. SURPASS study
    2.
  2. Tirzepatide
    3.
  3. SURPASS-3 tirzepatide
    4.
  4. SURPASS 4 tirzepatide
    5.
  5. Tirzepatide lancet
    6.
  6. Tirzepatide a potential new agent for type 2 diabetes
    7.
  7. SURPASS-CVOT
    8.
  8. Tirzepatide FDA
    9.